Eosinophils in allergic reactions

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 790-795

  Desreumaux, Pierre ^a   Capron, Monique ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CYTOKINE;

ALLERGIC REACTION; CHRONIC INFLAMMATION; EOSINOPHIL; SHORT SURVEY; TISSUE INJURY;

EID: 0030473831     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80006-9     Document Type: Article

References (59)

1. Desreumaux P, Bleget F, Seguy D, Capron M, Cortot A, Colombel J F, Janin A: lnterleukin-3, granulocyte macrophage-colony stimulating factor and interleukin-5 synthesis in eosinophilic gastroenteritis. Gastroenterology 1996, 110:768-774.
2. Wallaert B, Desreumaux P, Coppin MC, Tillie I, Benard A, Colombel JF, Gosselin B, Tonnel AB, Janin A: Immunoreactivily for interleukin-3, -5 and granulocyte-macrophage colony stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995, 182:1897-1904. Increased numbers of lymphocytes, eosinophils and mast cells associated with intracellular staining for IL-3, IL-5 and GM-CSF are detected in the gut mucosa of asthmatic and atopic patients without gastrointestinal symptoms, suggesting that the whole mucosal immune system is involved in bronchial asthma.
3. Desreumaux P, Janin A, Colombel JF, Prin L, Plumas J, Emilie D, Torpier G, Capron A, Capron M: Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992, 175:293-296
4. Sullivan S, Broide DH: Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J Allergy Clin Immunol 1996, 97:968-976.
5. Wardlaw AJ, Syrnon FS, Walsh GM. Eosinophil adhesion in allergic inflammation. J Allergy Clm Immunol 1994, 94:1163-1171
6. Pretolani M, Ruffle C, Silva JRL, Joseph D, Lobb RR, Vargaftig BB: Antibody to very late activation antigen 4 prevents antigen-induced branchial hyper-reactivity and cellular infiltration in the guinea pig airways. J Exp Med 1994, 180:795-805.
7. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I: Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment in the tissue. J Exp Med 1994, 179:1145-1154.
8. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP: IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995, 154:799-803. IL-13, like IL-4, selectively stimulates human umbilical vein endothelial cells to express VCAM-1 and to selectively adhere to VLA-4-expressing eosinophils but not to neutrophils.
9. Resnick MB, Colgan SP, Parkos CA, Delp-Archer C, McGuirk D, Weller PF, Madara JL: Human eosinophils migrate across an intestinal epithelium in response to platelet-activating factor. Gastroenterohgy 1995, 108:409-416.
10. Broide DH, Paine MM, Firestein GS: Eosinophils express Interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992, 90:1414-1424.
11. Weller PF: Lipid, peptide and cytokine mediators elaborated by eosinophils. In Immunopharmacology of Eosinophils. Edited by Smith H, Cook RM. London: Academic Press Incorporated; 1993:25-42.
12. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990, 71:258-265.
13. Elbon CL, Jacoby DB, Fryer AD: Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs. Am J Resp Cell Mol Biol 1995, 12:320-328. In order to investigate the hypothesis that eosinophils cajse M2 muscarinic receptor dysfunction, ovalbumin-sensitized guinea pigs were treated with TRFK-5, a monoclonal antibody to IL-5, before an aerosol challenge with ovalbumin. In antibody-treated animals the migration of eosinophils into the lungs was inhibited and the M2 receptor function was normal. In contrast, the function of M2 muscarinic autoraceptors on parasympathstic nerves was decreased in the lungs of untreated challenged animals. The function of M2 muscarinic receptors can thus be protected by inhibiting eosinophil influx into the lung.
14. Tanaka Y, Delaporte E, Dubucquoi S, Soussi Gounni A, Porchet E Capron A, Capron M: Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994, 103:589-592.
15. Dubucquoi S, Janin A, Klein O, Desreumaux P, Quandalle P, Cortot A, Capron M, Colombel JF: Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995, 37:242-246. Eosinophil infiltration of the neoileum occurs as soon as three months after radical surgery for Crohn's disease. Ultrastructural analysis revealed the state of activation of eosinaphils located in diseased areas, whereas IL-5 mRNA was detected by in situ hybridization Local IL-5 synthesis associated with eosinophil activation within tissues can participate in early mucosal damage in Crohn's disease.
16. Weber M, Dahinden CA: Basophil and eosinophil activation by CC chemokines Int Arch Allergy Immunol 1995, 107:148-150.
17. Dahinden CA, Geiser T, Brunner T, Von Tscharner V, Caput D, Ferrara P, Minty A, Baggiolini M: Monocyte chemotactic protein 3 is most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994, 179:751-756.
18. Noso N, Proost P, Van Damme J, Schroder JM: Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994, 200:1470-1476.
19. Ying S, Taborda-Barata L, Meng O, Humbert M, Kay AB; The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosmophil, T cell, and macrophage recruitment J Exp Med 1995, 181:2153-2159. Immunocylochemistry and in situ hybridization were used to evaluate the presence of RANTES and MCP-3 in the skin of atopic subjects after allergen challenga. MCP-3 was involved in the early eosinophil response whereas RANTES seemed more relevant to the later accumulation of T cells and macrophages.
20. Lukacs NW, Stricter RM, Shaklee CL, Chansue SW, Kunkel S: Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. Eur J Immunol 1995, 25:245-251. Airway inflammation was induced by intratracheal challenge wild a parasite antigen (egg antigen of Schistosoma mansoni) in presensitized mice. A significant increase of MIP-1α mRNA and protein expression was detected after challenge. MIP-1α was immunolocalized in macrophages and eosinophils present in the bronchoalveolar lavage fluids. Treatment with neutralizing MIP-1α antibodies revealed a specific decrease in eosinophil recruitment to the lungs and airways.
21. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Dim T, Ida N: Increased MCP-1. RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996, 153:1398-1404.
22. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995, 182:1169-1174.
23. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P: Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995, 181:1211-1216. Eotaxin caused a selective infiltration of eosinophils when injected into the lungs and skin of guinea pigs. Eotaxin mRNA levels were increased in response to allergen challenge in ovalbumin-sensitized guinea pigs, during the late-phase response Constitutive eotaxin mRNA expression was detected in multiple tissues.
24. Garcia-Zepeda EA, Rothenberg ME. Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia, Nat Med 1996, 2:449-456. Human eotaxin is directly chemotactic for eosinophils but not for mononuclear cells or neutrophils. It is an early response gene of cytokine-stimulated epithelial and endothelial cells, and is induced in eosinophils by IL-3. Eotaxin mRNA is particularly expressed in the lesions of patients with inflammatory bowel disease.
25. Ponath PD, Oin S, Ringler DJ, dark-Lewis I, Wuang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W et al.: Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996, 97:604-612. The human eosinotaxin gene has been cloned and the translated product is a strong and specific eosinophil chemoattractant in vitro and in vivo when injected into the skin of a rhesus monkey. Competition experiments reveal the existence of a high-affinity receptor on human eosinophils, which also binds to RANTES and MCP-3.
26. Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Hensche Lima SH, Li Y, Kreider B, Garotta G, Thelen M, Baggiolini M: Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996, 183:2379-2384.
27. Power CA, Myer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AEI, Wells TNC: Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995, 270:19495-19500.
28. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotma A, Springer MS: Cloning, expression and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996, 183:2349-2354. A new G-protein-coupled receptor, CC-CKR3, was cloned from human eosinophils. It binds eotaxin MCP-3 and RANTES with high affinity. It is specifically expressed by eosinophils, providing a potential mechanism for the selective tissue recruitment of eosinophils.
29. Gleich GJ, Adolphson CR: The eosinophilic leukocyte: structure and function. Adv Immunol 1986, 39:177-253.
30. Borrego L, Maynard B, Peterson EA, George T, Iglesias L, Peters MS, Newman W. Gleich GJ, Leiferman KM: Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Am J Pathol 1996, 148:897-909.
31. Kite H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ: Granulocyte-macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Erp Med 1991, 174:745-748.
32. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, Kay AB: Expression of mRNA and immunoreactiviry for the granulocyte macrophage-colony stimulating factor in activated human eosinophils. J Exp Med 1991, 174:749-752.
33. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DTW, Gordon JR, Dvorak AM, Weller PF, Galli SJ: Human eosinophils can express the cytokines tumor necrosis factor alpha and macrophage inflammatory protein-1 alpha. J Clm Invest 1993, 91:2673-2634.
34. + lymphocytes and eosinophils.
35. Weller PF, Rand TH, Barett T, Elovic A, Wong DT, Finberg RW: Accessory cell function of human eosinophils: HLADR dependent, MHC-restricted antigen-presentation and interleukin-1α. expression. J Immunol 1993, 150:2554-2562.
36. Hamid Q, Barkans J, Meng Q, Ying S, Abrams JS, Kay AB, Moqbel R: Human eosinophils synthesize and secrete IL-6 in vitro Blood 1992, 80:1496-1501.
37. Braun RK, Franchini M, Erard F, Rihs H, De Vries UM, Blaser K, Hansel TT, Walker C: Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 1993, 23:956-960.
38. Youseti S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser K, Simon HU: IL-B is expressed by human peripheral blood eosinophils. J Immunol 1995, 154:5481-5490.
39. Beil WJ, Weller PF, Tzizik PM, Galli SJ, Dvorak AM: Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J Histochenn Cytochem 1993, 41:1611-1615.
40. 1. Blood 1991, 78:2702-2707.
41. Elovic A, Wong DTW, Weller PF, Matossian K, Galli SJ: Expression of transforming growth factors-α and β1 messenger RNA and product by eosinophils in nasal polyps. J Allergy clin Immunol 1994, 93:864-869.
42. Nonaka M, Nonaka R, Wooley K, Adelroth E, Miura K, Okhawara Y, Glibetic M, Nakano K, O'Byrne P, Dolovich J, Jordana M: Distinct immunohistochemical localization of IL-4 In human inflamed airway tissues. J Immunol 1995, 155:3234-3244. Immunostaining procedures revealed the existence of IL-4-positive eosinophils in nasal polyp tissues and, to a lesser extent, in bronchial tissues, both from asthmatic patients. Stimulation of purified blood eosinophils with slgA immune complexes induced expression of IL-4 mRNA and the release of IL-4 into the supernatants. Eosinophils can be considered as a primary source of IL-4 in tissues during mucosal inflammation.
43. Moqbel R, Ying S, Barkans J, Newman TM, Kimmit P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham SR, Kay AB: Identification of messenger RNA for IL-4 in human eosinophils with granule localization end release of the translated product J Immunel 1995, 155:4939-4947. IL-4 mRNA was detected by reverse transcription-polymerase chair reaction in blood eosinophils from atopic asthmatics. By enzyme-linked immunosorbent assay, IL-4 was quantified in whole cell extracts and 30% was released in the supernatants from activated cells. Immunocytochemistry revealed that IL-4 is located in the crystalloid of eosinophil granules. Eosinophils can thus contribute to the development of the Th2 phenolype as well as to IgE synthesis.
44. Levi-Schaffer F, Barkans J, Newman TM, Ying S, Wakalin M, Hohenstein R, Barak V, Lacy P, Kay AB, Moqbel R: Identification of interleukin 2 in human peripheral blood eosinophils. Immunology 1996, 87:155-161.
45. Lamkhioued B, Aldebert D, Soussi Gounni A, Delaporte E, Goldman M, Capron A, Capron M: Synthesis of cytokines by eosinophils and their regulation. Int Arch Allergy Immunol 1995, 107:122-123. Eosinophils from eosinophilic patients can synthesize IFN-γ and IL-10, as shown for the first time by in situ hybridization and immunostaining.
46. Hamid Q, Azzawi M, Ying S. Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffary PK et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991, 87:1541-1546.
47. Fujisawa T, Abu Ghazaleh R, Kita H, Sanderson CJ: Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990, 144:642-646.
48. Capron M, Truong MJ, Desreumaux P, Lamkhioued B, Tomassini M, Capron A: Eosinophil membrane receptors: function of IgE and IgA binding molecules. In Eosinophils in Allergy and Inflammation. Edited by Kay AB, Gleich GL. New York: Dakker M Incorporated; 1994, 11:225-237.
49. Soussi Gounni A, Lamkhioued B, Ochiai K, Tanaka Y, Delaporta E, Capron A, Kinet JP, Capron M: High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994, 367:183-186.
50. Tomassiri M, Tsicopoulos A, Tai PC, Gruart V, Tonnel AB, Prin L, Capron A, Capron M: Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia an immunoglobulin-dependent activation. J Allergy Clin Immunol 1991, 88:365-375.
51. Terada N, Konno A, Terada Y, Fukuda S, Yamashita T, Abe T, Shimada H, Ishida K, Yoshimura K, Tanaka Y et al.: IL-4 upregulates FcεRI α-chain messenger RNA in eosinophils. J Allergy Clin Immunol 1995, 96:1161-1169. Reverse transcription polyrnerase chain reaction and Southern blot hybridization allow the detection of FcεRI α-chain mRNA in purified blood eosinophils from four out of five patients with allergic rhinitis; expression was increased by IL-4. Flow cytometry or immunostaining did not reveal the expression of FcεRI on peripheral blood eosinophils; however, some ECP-positive cells expressed FcεRI in the nasal mucosa. These data confirm that FcεRI could be synthesized by eosinophils themselves and that its expression is correlated with eosinophil activation.
52. Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrinck JL, Bergoend H, Janin A, Capron M: IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 1996, in press.
53. Maurer D, Ebner C, Reiniger B, Fiebiger E, Kraft D, Kinet JP, Stingl G: The high affinity IgE receptor (FcepsilonRI) mediates IgE-dependent allergen presentation. J Immunol 1995, 154:6285-6290.
54. Abu Ghazaleh R, Fujisawa T, Mestecky J, Kyle A, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol 1989, 142:2393-2400.
55. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland L, Kubagawa H: Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Intvest 1993, 92:1681-1665.
56. Lamkhioued B, Soussi Gounni A, Gruart V, Pierce A, Capron A, Capron M: Human eosinophils express a receptor for secretory component Role in secretory IgA-dependent activation. Eur J Immunol 1995, 26:117-125. Flow cytometry and various binding procedures showed the existence of a specific receptor lor SC on purified human eosinophils. This 15kDa molecule binds to SC or slgA but not to serum IgA, and can mediate eosinophil degranulation induced by SC or slgA immune complexes. The existence of such a receptor might explain the preferential degranulation induced by slgA, and strengthen the probable involvement of eosinophils in mucosal immunity.
57. Dubucquoi S, Desreumaux P, Janin A, Goldman M, Tavernier J, Capron A, Capron M: Synthesis of interleukin-5 by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994, 179:703-708.
58. Egesten A, Calafat J, Knol EF, Janssen H, Welz TM: Subcellular localization of TGF-α in human eosinophil granulocytes. Blood 1996, 87:3910-3918.
59. Miyamasu M, Hirai K, Takahashi Y, lida M, Yamaguchi M, Koshino T, Takaishi T, Morita Y, Ohta K, Kasahara T, Ito K: Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 1995, 154:1339-1349. In order to examine the role of the physiological stimuli that trigger ensinophils to generate cytokines, the authors show that C5a and FMLP but not platelet-activating factor or C-C chemokines (RANTES, MIP-1α, MIP-1β) induce the release of IL-8 and GM-CSF by eosinophils, but only in the presence of cytochalasin B.